These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21207049)

  • 1. A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.
    Poljansky S; Ibach B; Hirschberger B; Männer P; Klünemann H; Hajak G; Marienhagen J
    Eur Arch Psychiatry Clin Neurosci; 2011 Sep; 261(6):433-46. PubMed ID: 21207049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
    Womack KB; Diaz-Arrastia R; Aizenstein HJ; Arnold SE; Barbas NR; Boeve BF; Clark CM; DeCarli CS; Jagust WJ; Leverenz JB; Peskind ER; Turner RS; Zamrini EY; Heidebrink JL; Burke JR; DeKosky ST; Farlow MR; Gabel MJ; Higdon R; Kawas CH; Koeppe RA; Lipton AM; Foster NL
    Arch Neurol; 2011 Mar; 68(3):329-37. PubMed ID: 21059987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
    Rabinovici GD; Rosen HJ; Alkalay A; Kornak J; Furst AJ; Agarwal N; Mormino EC; O'Neil JP; Janabi M; Karydas A; Growdon ME; Jang JY; Huang EJ; Dearmond SJ; Trojanowski JQ; Grinberg LT; Gorno-Tempini ML; Seeley WW; Miller BL; Jagust WJ
    Neurology; 2011 Dec; 77(23):2034-42. PubMed ID: 22131541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
    Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
    Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study.
    Woost TB; Dukart J; Frisch S; Barthel H; Sabri O; Mueller K; Schroeter ML
    Neuroimage Clin; 2013; 2():746-58. PubMed ID: 24179826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic connectivity for differential diagnosis of dementing disorders.
    Titov D; Diehl-Schmid J; Shi K; Perneczky R; Zou N; Grimmer T; Li J; Drzezga A; Yakushev I
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):252-262. PubMed ID: 26721391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.
    Kang JM; Lee JY; Kim YK; Sohn BK; Byun MS; Choi JE; Son SK; Im HJ; Lee JH; Ryu YH; Lee DY
    Mol Diagn Ther; 2018 Aug; 22(4):475-483. PubMed ID: 29761365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Amyloid versus
    Lesman-Segev OH; La Joie R; Iaccarino L; Lobach I; Rosen HJ; Seo SW; Janabi M; Baker SL; Edwards L; Pham J; Olichney J; Boxer A; Huang E; Gorno-Tempini M; DeCarli C; Hepker M; Hwang JL; Miller BL; Spina S; Grinberg LT; Seeley WW; Jagust WJ; Rabinovici GD
    Ann Neurol; 2021 Feb; 89(2):389-401. PubMed ID: 33219525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
    Rostomian AH; Madison C; Rabinovici GD; Jagust WJ
    J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy.
    Frisch S; Dukart J; Vogt B; Horstmann A; Becker G; Villringer A; Barthel H; Sabri O; Müller K; Schroeter ML
    PLoS One; 2013; 8(2):e55251. PubMed ID: 23457466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in cerebral glucose metabolism between frontotemporal lobar degeneration and Alzheimer's disease].
    Poljansky S; Ibach B; Vogel M; Männer P; Marienhagen J; Hajak G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S73-5. PubMed ID: 15570509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.
    Inui Y; Ito K; Kato T;
    J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between clinical characteristics and neuroimaging in Chinese patients with subtypes of frontotemporal lobe degeneration.
    Shi Z; Liu S; Wang Y; Liu S; Han T; Cai L; Zhou Y; Gao S; Ji Y
    Medicine (Baltimore); 2017 Sep; 96(37):e7948. PubMed ID: 28906375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.
    Della Rosa PA; Cerami C; Gallivanone F; Prestia A; Caroli A; Castiglioni I; Gilardi MC; Frisoni G; Friston K; Ashburner J; Perani D;
    Neuroinformatics; 2014 Oct; 12(4):575-93. PubMed ID: 24952892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.